To determine whether higher levels of PaO2 are associated with in-hospital mortality and poor neurological status at hospital discharge in patients treated with mild therapeutic hypothermia after sudden cardiac arrest.
Retrospective analysis of a prospective cohort.
A total of 170 consecutive patients treated with therapeutic hypothermia in the cardiovascular care unit of an academic tertiary care hospital.
Of 170 patients, 77 (45.2%) survived to hospital discharge. Survivors had a significantly lower maximum PaO2 (198 mm Hg; interquartile range, 152.5–282) measured in the first 24 hrs following cardiac arrest compared to nonsurvivors (254 mm Hg; interquartile range, 172–363; p = .022). A multivariable analysis including age, time to return of spontaneous circulation, the presence of shock, bystander cardiopulmonary resuscitation, and initial rhythm revealed that higher levels of PaO2 were significantly associated with increased in-hospital mortality (odds ratio 1.439; 95% confidence interval 1.028–2.015; p = .034) and poor neurological status at hospital discharge (odds ratio 1.485; 95% confidence interval 1.032–2.136; p = .033).
Higher levels of the maximum measured PaO2 are associated with increased in-hospital mortality and poor neurological status on hospital discharge in patients treated with mild therapeutic hypothermia after sudden cardiac arrest.
From the Department of Internal Medicine (JSP), Division of Allergy, Pulmonary and Critical Care Medicine (DRJ, TWR), and the Division of Cardiovascular Medicine (RDH, JAM), Vanderbilt University School of Medicine, Nashville, TN.
*See also p. 3306.
Drs. Janz, Hollenbeck, and Rice conceived the study design. Drs. Janz, Hollenbeck, and Pollock collected data and Drs. Janz and Rice analyzed the data. All authors participated in interpretation of the results. Dr. Janz drafted the manuscript, and all authors contributed to the critical review and revision of the manuscript. All authors have seen and approved the final version of the manuscript.
Supported, in part, by the National Institutes of Health (HL81431) for financial support used in the analysis and interpretation of this data.
The authors have not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: firstname.lastname@example.org